Increased expression of the interleukin-10 gene by alveolar macrophages in interstitial lung disease

American Journal of Physiology

Volumn 273, Issue 3 PART 1, 1997, Pages

  Baddini Martinez, Jose A ^a   King Jr , Talmadge E ^a   Borish, Larry ^a   Mortenson, Rebecca L ^a   Khan, Talat Z ^a   Bost, Thomas W ^a   Riches, David W H ^a  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33745407629     PISSN: 00029513     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Abrams, J. S., M.-G. Roncarolo, H. Yssel, U. Andersson, G. J. Gleich and J. E. Silver. Strategies of anti-cytokine monoclonal antibody development: immunoassay of IL-10 and IL-5 in clinical samples. Immunol. Rev. 127: 5-24, 1992.
2. Bach wich, P. R., J. P. Lynch III, J. Larrick, M. Spengler, and S. L. Kunkel. Tumor necrosis factor production by human sarcoid alveolar macrophages. Am. J. Pathol. 125: 421-425, 1986.
3. Bonfield, T. L., M. W. Konstan, P. Burfeind, J. R. Panuska, J. B. Billiard, and M. Berger. Normal bronchial epithelial cells constitutively produce the anti-inflammatory cytokine interleukin-10, which is down-regulated in cystic fibrosis. Am. J. Respir. Cell Mol. Biol. 13: 257-261, 1995.
4. Bost, T. W., D. W. H. Riches, B. Schumacher, P. C. Carré, T. Z. Khan, J. A. B. Martinez, and L. S. Newman. Alveolar macrophages from patients with beryllium disease and sarcoidosis express increased levels of mRNA for TNF-α and IL-6 but not IL-l. Am. J. Respir. Cell Mol. Biol. 10: 506-513, 1994.
5. Carré, P. C., T. E. King, Jr., R. Mortensen, and D. W. H. Riches. Crypogenic organizing pneumonia: increased expression of interleukin-8 and fibronectin genes by alveolar macrophages. Am. J. Respir. Cell Mol. Biol. 10:100-105, 1994.
6. Carré, P. C., R. L. Mortenson, T. E. King, Jr., P. W. Noble, C. L. Sable, and D. W. H. Riches. Increased expression of the interleukin-8 gene by alveolar macrophages in idiopathic pulmonary fibrosis. J. Clin. Invest. 88: 1802-1810, 1991.
7. Chen, W. F., and A. Zlotnik. IL10: a novel cytotoxic T cell differentiation factor. J. Immunol. 147: 528-534, 1991.
8. Doherty, D. E., G. S. Worthen, and P. M. Henson. Inflammation in interstitial lung disease. In: Interstitial Lung Disease, edited by M. I. Schwarz and T. E. King, Jr. St. Louis, MO: Mosby, 1993, p. 23-43.
9. Fiorentino, D. F., M. W. Bond, and T. R. Mossman. Two types of mouse helper T cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Thl clones. J. Exp. Med. 170: 2081-2095, 1989.
10. Fleming, S. D., and P.A. Campbell. Macrophages have surface IL-10 that regulates macrophage bactericidal activity. J. Immunol. 156: 1143-1150, 1996.
11. Hyde, D. M., T. S. Henderson, S. N. Giri, N. K. Tyler, and M. Y. Stovall. Effect of murine gamma interferon on the cellular response to bleomycin in mice. Exp. Lung Res. 14: 687-704, 1988.
12. Kawanami, O., V. J. Ferrans, and J. D. Fulmer. Ultrastructure of pulmonary mast cells in patients with fibrotic lung disorders. Lab. Invest. 49: 717-734, 1979.
13. Kindler, V., A.-P. Sappino, G. E. Grau, P.-F. Piguet, and P. Vassalli. The inducing role of tumore necrosis factor in the development of bacterial granulomas during BCG infection. Cell 56: 731-740, 1989.
14. King, T. E., Jr. Idiopathic pulmonary fibrosis. In: Interstitial Lung Disease, edited by M. I. Schwarz and T. E. King, Jr. St. Louis, MO: Mosby, 1993, p. 367-403.
15. King, Jr., T. E., and R. L. Mortenson. Crytogenic organizing pneumonia: the North American experience. Chest Suppl. 102: 8S-13S, 1992.
16. Kühn, R., J. Löhler, D. Rennick, K. Rajewsky, and W. Müller. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75: 263-274, 1993.
17. Laszlo, D. J., P. M. Henson, L. K. Remigio, L. Weinstein, C. Cable, P. W. Noble, and D. W. H. Riches. Development of functional diversity in mouse macrophages. Mutual exclusion of two phenotypic states. Am. J. Pathol. 143: 587-597, 1993.
18. Nash, J. R., P. J. McLaughlin, D. Butcher and B. Corrin. Expression of tumour necrosis factor-alpha in cryptogenic fibrosing alveolitis. Histopathology 22: 343-347, 1993.
19. Oswald, I. P., T. A. Wynn, A. Sher, and S. L. James. Interleukin-10 inhibits macrophage microbicidal activity by blocking the endogenous production of tumor necrosis factor-α required as a costimulatory factor for interferon-γ induced activation. Proc. Natl. Acad. Sci. USA 89: 8676-8680, 1992.
20. Peryol, S., F. J. Cordier, and J. A. Grimaud. Intraalveolar fibrosis of idiopathic bronchiolitis obliterans organizing pneumonia. Cell-matrix patterns. Am. J. Pathol. 137: 155-170, 1990.
21. Phan, S. E., and S. L. Kunkel. Lung cytokine production in bleomycin-induced pulmonary fibrosis. Exp. Lung Res. 18: 2943, 1992.
22. Piguet, P. E., M. A. Collart, G. E. Grau, Y. Kapanci, and P. Vassalli. Tumor necrosis factor/cachectin plays a key role in bleomycin-induced pneumopathy and fibrosis. J. Exp. Med. 170: 655-663, 1989.
23. Piguet, P. F., C. Ribaux, V. Karpuz, G. E. Grau, and Y. Kapanci. Expression and localization of tumor necrosis factoralpha and its mRNA in idiopathic pulmonary fibrosis. Am. J. Pathol. 143: 651-655, 1993.
24. Piguet, P. F., and C. Vesin. Treatment by human recombinant soluble TNF receptor of pulmonary fibrosis induced by bleomycin or silica in mice. Eur. Respir. J. 7: 515-518, 1994.
25. Rousset, F., E. Garcia, T. De France, C. Perrone, N. Vezzio, D. H. Hsu, R. Kastelein, K. W. Moore, and J. Banchereau. Interleukin 10 is a potent growth factor and differentiation factor for activated human B lymphocytes. Proc. Natl. Acad. Sci. USA 89: 1890-1893, 1992.
26. Schwarz, M. I. Clinical overview of interstitial lung disease. In: Interstitial Lung Disease, edited by M. I. Schwarz and T. E. King, Jr. St. Louis, MO: Mosby, 1993, p. 1-22.
27. Seckinger, P., S. Isaaz, and J.-M. Dayer. Purification and biologic characterization of a specific tumor necrosis factor alpha inhibitor. J. Biol. Chem. 264: 11966-11973, 1989.
28. The BAL Cooperative Group Steering Committee. Bronchoalveolar lavage constituents in healthy individuals, idiopathic pulmonary fibrosis, and selected comparison groups. Am. Rev. Respir. Dis. 141: S169-S202, 1990.
29. Thompson-Snipes, L., V. Dhar, M. W. Bond, T. R. Mosmann, K. W. Moore, and D. M. Rennick. Interleukin 10: a novel stimulatory factor for mast cells and their progenitors. J. Exp. Med. 173: 507-510, 1991.
30. Wanidworanun, C., and W. Strober. Predominant role of tumor necrosis factor- in human monocyte IL-10 synthesis. J. Immunol. 151: 6853-6861, 1993.
31. Watters, L. C., T. E. King, M. I. Schwarz, J. A. Waldron, R. E. Stanford, and R. M. Cherniack. A clinical, radiographie, and physiologic scoring system for the longitudinal assessment of patients with pulmonary fibrosis. Am. Rev. Respir. Dis. 133: 97-103, 1986.
32. Watters, L. C., M. I. Schwarz, R. M. Cherniack, J. A. Waldron, T. L. Dünn, R. E. Stanford, and T. E. King. Pretreatment bronchoalveolar lavage cellular constituents and their relationships with lung histopathology and clinical response to therapy. Am. Rev. Respir. Dis. 135: 696-704, 1987.
33. Willcox, M. L., A. Kervitsky, L. C. Watters, and T. E. King, Jr. Quantification of cells recovered by bronchoalveolar lavage. Comparison of cytocentrifuge preparations to the filter method. Am. Rev. Respir. Dis. 138: 74-80, 1988.
34. Wogensen, L., X. Huang, and N. Sarvetnick. Leukocyte extravasation into the pancreatic tissue in transgenic mice expressing interleukin 10 in the islets of Langerhans. J. Exp. Med. 178:175-185, 1993.
35. Zhang, Y., T. C. Lee, M. Guillemin, M. C. Yu, and W. N. Rom. Enhanced IL-1 and tumor necrosis factor-α release and messenger RNA expression in macrophages from idiopathic pulmonary fibrosis or after asbestos exposure. J. Immunol. 150: 4188-4196, 1993.